With having shown a positive effect of hPL+ on osteogenic differentiation in our study compared to FCS, this may aid in tissue engineering for the treatment of bone loss disorders like osteoporosis, where the acceleration of osteogenesis is needed. This evidence concerns the gene LGALS1 and osteoporosis.